WILATE human coagulation factor VIII 450IU and von Willebrand factor 400 IU powder for injection vial with diluent vial

البلد: أستراليا

اللغة: الإنجليزية

المصدر: Department of Health (Therapeutic Goods Administration)

العنصر النشط:

Von willebrand factor, Quantity: 400 IU; Factor VIII, Quantity: 7.5 mg; Factor VIII, Quantity: 450 IU

متاح من:

Octapharma Australia Pty Ltd

INN (الاسم الدولي):

Factor VIII,Von willebrand factor

الشكل الصيدلاني:

Injection, powder for

تركيب:

Excipient Ingredients: tributyl phosphate; sucrose; sodium citrate dihydrate; sodium chloride; calcium chloride dihydrate; octoxinol 9; glycine

طريقة التعاطي:

Intravenous

الخصائص العلاجية:

1. Von Willebrand disease (VWD): treatment of bleeding episodes including surgical bleeding in patients with von Willebrand's disease when desmorpressin treatment is effective or contraindicated. 2. Haemophilia A: treatment and prophylaxis of bleeding including surgical bleeding in patients with haemophilia A (congenital FVIII deficiency). There are insifficient data to recommend the use of Wilate in children less than 12 years of age.

ملخص المنتج:

Visual Identification: White or pale yellow or friable solid.;

الوضع إذن:

Licence status A

تاريخ الترخيص:

2007-09-26